2020-2021 Oncology Nursing Drug Handbook (23rd Revised Edition)

Rs. 17,200
  • Authors: Gail M. Wilkes, Margaret Barton-Burke
  • ISBN: 9781284171327
  • Publisher: Jones and Bartlett Publishers
  • Edition: 23rd
  • Publication Date: December 04, 2019
  • Format: Paperback – 2018 pages
  • Language: English

Out of stock



Share
Description

Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.

Key Features
  • Provides valuable information on effective symptom management, patient education, and chemotherapy administration.
  • Completely revised and updated, includes separate chapters on molecular and immunologic/biologic targeted therapies
  • Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
  • Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
  • New drugs include: apalutamide (Erleada™), calaspargase pegol-mknl (Asparlas™), Daunorubicin and cytarabine liposome for injection (Vyxeos®), glucarpidase (Voraxaze®), alpelisib (Piqray®), binimetinib (Mektovi®), dacomitinib (Vizimpro®), Duvelisib (Copiktra®), encorafenib (Braftovi®), erdafitinib (Balversa™), lorlatinib (Lorbrena®), anakinra (Kineret®), baricitinib (Olumiant®), sarilumab (Kevzara®), aprepitant injectable emulsion (Cinvanti®), granisetron hydrochloride extended-release injection (Sustol®), letermovir (Prevymis™), omadacycline (Nuzyra™), meropenem/vaborbactam (Vabomere™), Plazomicin (Zemdri™), baloxavir marboxil (Xofluza™), imipenem/cilastatin sodium/relebactam (Recarbrio™), eravacycline (Xerava™), delafloxacin (Baxdela™)
Authors Biography

Gail M. Wilkes, MS, APRN-BC, AOCN;

Margaret Barton-Burke, PhD, RN, FAAN;

Additional information
Weight1.729 kg
Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.